4//SEC Filing
ProNAi Therapeutics Inc 4
Accession 0001209191-17-001599
CIK 0001290149operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:22 PM ET
Size
5.6 KB
Accession
0001209191-17-001599
Insider Transaction Report
Form 4
Kowalski Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy Class A Common Stock)
2017-01-03+300,000→ 300,000 totalExercise: $1.54Exp: 2027-01-03→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on January 3, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 3, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
ProNAi Therapeutics Inc
CIK 0001290149
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001290149
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 8:22 PM ET
- Size
- 5.6 KB